IL6 and ovarian neoplasm: Inordinately elevated IL-6 may drive, via the IL6/IER3 signaling axis, chemoresistance and disease recurrence of ovarian tumors; higher levels of IL-6 and VEGA-A were significantly associated with shorter progression-free survival [46,47,48].